Table 2. Protein expression of PARC in lung tissue and intercostal arteries, according to groups.
Tissue | Parameters | COPD | NOS | NS | Overall P-value |
---|---|---|---|---|---|
Lung | |||||
Number of arteries measured in each subject | 10.2±1.6 | 12.4±1.6 | 9.9±1.9 | 0.365 | |
% Positive immunoreaction | 72.3 ± 8.1 | 57.6 ± 8.1 | 42.9 ± 9 | 0.063 | |
Endothelial layer * | 0.02 ± 0.03 | 0.07 ± 0.03 | 0.08 ± 0.03 | 0.443 | |
Intimal thickening * | 0.20 ± 0.07 | 0.13 ± 0.07 | 0.16 ± 0.08 | 0.772 | |
Muscular layer * | 1.23 ± 0.15 | 0.86 ± 0.15 | 0.61 ± 0.16 | 0.023 | |
Adventitial layer* | 0.15 ± 0.08 | 0.1 ± 0.08 | 0.05 ± 0.09 | 0.68 | |
Alveolar parenchyma* | 1.33 ± 0.13 | 1.13 ± 0.13 | 0.83 ± 0.15 | 0.059 | |
Bronchial structures | |||||
% Positive immunoreaction | 79.9 ± 9 | 59.9 ± 8.7 | 68.7 ± 9.4 | 0.293 | |
Bronchial epithelium* | 0.59 ± 0.12 | 0.41 ± 0.12 | 0.6 ± 0.12 | 0.441 | |
SEBM* | 0.1 ± 0.06 | 0.05 ± 0.06 | 0.03 ± 0.06 | 0.7 | |
Connective tissue* | 0.49 ± 0.14 | 0.53 ± 0.14 | 0.3 ± 0.15 | 0.511 | |
ASM* | 0.1 ± 0.08 | 0.21 ± 0.08 | 0.03 ± 0.08 | 0.242 | |
Intercostal artery | |||||
Endothelial layer* | 0.38 ± 0.2 | 0.31 ± 0.23 | 0.33 ± 0.24 | 0.975 | |
Intimal thickening* | 0.31 ± 0.16 | 0.15 ± 0.18 | 0.42 ± 0.19 | 0.597 | |
Muscular layer* | 1.19 ± 0.23 | 1.08 ± 0.26 | 1.58 ± 0.27 | 0.362 | |
Adventitial layer* | 0.56 ± 0.17 | 0.54 ± 0.19 | 0.75 ± 0.2 | 0.694 |
Data are presented as LSM ± SEM. The reported p-value comes from the overall comparison with ANCOVA method with a general linear model using as covariables: gender, pack-years and the presence of diabetes mellitus.
*Label intensity was scored as negative (0), mild (1), moderate (2), and strongly positive (3). The percentage of positive structures and the average score were computed for pulmonary muscular arteries and bronchial structures in each subject. COPD: Chronic Obstructive Pulmonary Disease; NOS: non-obstructed smokers; NS: never-smokers.